One Stop Shop
November 7, 2021
In a market filled with complexity, working with a single supplier simplifies the supply chain and focuses effort towards a single target
1 min read
In this month’s cover feature, we put a spotlight on professionals from the outsourcing sector, who share their thoughts on the role of CDMOs in the global fight against COVID-19. In a second mini feature, we also explore how the industry is working to update clinical trials. Meanwhile, in Business, IDEA Pharma’s Mike Rea explains how a crucial moment in his career inspired the launch of his pharmaceutical positioning company, while Paula Pulsoni from World Courier discusses the importance of responding to changing logistics demands as global supply chains change. Also in this issue, we look at a pill for monoclonal antibodies, autoinjectors, multi-omics, lessons learned from Operation Warp Speed, and we we catch up with Novartis about progress towards the eradication of malaria. Finally, Evelina Vågesjö from Ilya Pharma tell us what it’s like to be a CEO at a spin out company.
November 7, 2021
In a market filled with complexity, working with a single supplier simplifies the supply chain and focuses effort towards a single target
1 min read
October 27, 2021
Much praise has been lavished on pharma companies for quickly developing effective COVID-19 vaccines, but big pharma rarely works alone. CDMOs tend to fly under the radar of the general public, but their efforts have been absolutely crucial in our collective pandemic response. Here, we ask five CDMO gurus how they reacted to COVID-19 – and how the pandemic will shape the future of outsourcing and collaboration.
1 min read
October 23, 2021
Work in Gwangju has brought medicine one step closer to effective membrane-permeable drugs
1 min read
October 22, 2021
Tell us which technologies rocked your world in 2021
1 min read
October 20, 2021
“Thank you for signing up for this clinical trial. We expect you to visit the trial site twice a month and fill in this daily diary… Wait, why are you all dropping out?” It’s high time pharma made improvements to the clinical trial process.
1 min read
October 19, 2021
Two studies scrutinize extreme drug pricing, sounding alarms for industry and policymakers
1 min read
October 18, 2021
A planned facility suddenly had to be up and running much faster than expected as it became part of Operation Warp Speed. Here’s how it was done.
1 min read
October 18, 2021
How partnering with organizations that provide specialist technical and regulatory knowledge can help reduce your development timelines, risks, and costs
1 min read
October 12, 2021
Sitting Down With… Evelina Vågesjö, Chief Executive Officer at Ilya Pharma, Uppsala, Sweden
1 min read
October 8, 2021
Some people do business by using the past to predict the future, but is this the best launch strategy for a new product?
1 min read
October 6, 2021
A pill developed at MIT could replace injections for monoclonal antibody therapies
1 min read
October 6, 2021
New technologies are driving a small molecule renaissance
1 min read
October 3, 2021
How can logistics companies meet the evolving needs of global clients while maintaining resilience in the long-term? One answer may be to adopt risk-reduced supply solutions by using local seamlessly-linked storage and delivery services.
1 min read
October 2, 2021
Meet the international coalition working to tackle COVID-19 in low- and middle-income countries
1 min read
September 29, 2021
We revisit our conversation with AstraZeneca’s George Kirk and ask what difference a medicine designed to treat a rare condition has made a year since its first approval
1 min read
September 28, 2021
BioMed X launches new projects in immune homeostasis and oral delivery of macromolecules
1 min read
September 27, 2021
Once we overcome the complex challenges presented by self-administered parenterals, we create a win-win-win situation: happier patients, better healthcare, and lighter workloads for doctors.
1 min read
September 21, 2021
If the World Health Organization aims to meet its goal of eradicating malaria by 2050, pharmaceutical companies will have to play a key role in the fight. In particular, changes will have to be made to diversify the offering of drugs available
1 min read
September 20, 2021
Biopharmaceutical development needs more speed, and greater efficiency – and multi-omics could well be the answer
1 min read
False
False